The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Many Thanks LimaLiam.....!
Thanks for all of these, they were reported earlier and will hopefully get remedied quickly.
Apologies Matterhorn, good stuff - I just saw that, am only getting to earlier threads now. Much catch up to do after yesterday's news.
Have only just got around to looking at the website as been in meetings this morning. Very pleasing to see the new corporate professional feel. All new lovely photos and a large amount of work put in. As others have said, you wouldn't do all of this unless you knew or had a very good inkling something good was about to happen! Well done the Synairgen team!
Fruits - LimaLiam has kindly offered to collate all issues on our behalf and to forward it on to Brooke.
Mattw007,
"On confirmation, they need it to take you to a page which says something like: "Thanks, you have now been registered to receive the alerts... blah, blah"
I got this message on a new window.....
"Thank you. Your subscription process has been completed successfully.
You can continue browsing."
Matterhorn,
If you have not already done so could you feed this back to Brooke via email maybe? All very valid and helpful feedback. I sent her through some minor point on Investor page yesterday and she actioned straight away.
1) Press Kit. In the Synairgen Logo guidance slide, ‘logos’ is spelled with an apostrophy ‘s’ which is wrong. An apostrophe indicates possession, not plural. (I recommend reading 'Eats, Shoots and Leaves'.)
2) Press kit. Folder containing the logo files and guides. The ‘2Col’ and ‘White’ RGB copies seem to be exactly the same. Not sure what the difference is.
3) Under the section Programmes the LOXL2 programme does not appear. Not sure whether this was deliberate or not. It used to be part of the old website.
4) Page relating to AIM rule 26. The layout is a bit weird and somewhat confusing. It doesn’t read well. For example ‘its country of incorporation and main country of operation;’ has a bullet point in front of it while the answer to this has no bullet point which is fine, but it’s positioned at the very left. This type of layout is repeated several times down the page. For some of the ‘questions’ the answer is ‘N/A’. Rather put ‘Not applicable’ as it looks like some error.
They need to redesign the layout of this page so that it’s less confusing to the reader.
5) Corporate Governance Statement page. If I expand ‘Principal 5’ for example and then scroll down so that ‘Principal 10’ is at the bottom of my screen without really leaving any space between the bottom of my screen and ‘Principal 10’s header, note ‘Principal 5’ is still expanded, then when I expand ‘Principal 10’ the page jumps right to the bottom of the website meaning I need to scroll back up to view the content of ‘Principal 10’ since expanding it.
On the 'Legal' page there are two missing links
Our Privacy Policy [INSERT AS LINK TO SITE'S PRIVACY POLICY].
Our Cookie Policy [INSERT AS LINK TO COOKIE POLICY], which sets out information about the cookies on our site.
The talk of the moment on Redditt property but they are too busy editing the website via Ms Brooke who has welcomed the comments I might add ;-)
Had anybody asked why they rushed to get the new shiny website up? Tick tock
I cannot find a select all on the interactive chart, ticking each country seems tedious. Maybe I missed it ?
Hmm. It would’ve definitely undergone (interferon haha) beta testing. The programming and design is virtually flawless and a huge improvement on the previous one. Hats off. I guess a few typos are inevitable and so long as they are being pounced on and corrected it’s all good.
I think they rush to get the site on line ,and in their rush didn't give it the vigorous testing needed .
Just beat me to it grazzyman :-)
https://www.synairgen.com/science/covid-19
SG018 completed recruitment in November 2021. You can read the press release here: Synairgen completes Phase III recruitment
No press release.
Also, one of the links from the COVID-19 page doesn't have content:
https://www.synairgen.com/media/synairgen-completes-phase-iii-recruitment
On the “Interferon B” page, in the section “ not all anti-virals are the same”, it mentions “directing acting anti-virals” - typo?
Minor issue in the press pack.... Synairgen state how important the 'x' gap round their logo is, then present 2 logos to use immediately to the right, which do not follow their own rule. Not important, I know, but if someone is being helpful making a list of errors, then thats one to add. :-)
I still don't know how I picked that one up...must have been looking in too much detail!
Was going to this morning, but Liam offered which is great.
Hats off to Brooke. This, the new website, is her baby. Absolutely outstanding work. She has really thought of everything - you name it, it’s there. In general the communication/PR has been top notch since she came on board.
Only other slight ‘issue’ is that the drop down box of the ‘What are you enquiring about’ on the ‘Contact’ page does not include an option to pre-order Synairgen branded Nyetimber :-) Jokes. Need to wrap the excitement for now.
No problem, I'll add that to the list, which is quite short, it's a great site!
Sorry Laim. Saw you are collating. Great work!
Matterhorn, Brooke has been responding to messages quickly about spelling errors etc on the new site. It is worth emailing her if you haven't done so already about the performance page issue.
The dark blue navigation panel at the bottom of the page is formatted a little strangely - almost like there's another column expected between "Interferon Beta" and "About"
Great, that's the one from yesterday. I'll give it half a day for anything else the pass it on.
Incidentally we can get RNS notifications directly from Synairgen now https://www.synairgen.com/investors/performance#email
Might be useful to those who arent using a push service elsewhere.